Tag: Healthcare Innovation Award

Maria Lithoxopoulou | Health Professions | Best Researcher Award

Published on by World Science Awards

Assist. Prof. Dr. Maria Lithoxopoulou | Health Professions | Best Researcher Award

Neonatologist -Pediatrics at Faculty of Medicine Aristotle University of Thessaloniki, Greece

Dr. Maria Lithoxopoulou is an esteemed Assistant Professor of Paediatrics-Neonatology at Aristotle University of Thessaloniki, Greece. With over 17 years of clinical experience as a Consultant Neonatologist, she has made significant contributions to neonatal care, focusing on neonatal infections, retinopathy of prematurity, and neonatal nutrition. She holds a Ph.D. in Neonatal Infections and an MBA in Health Administration, showcasing a blend of clinical, research, and administrative expertise. Her research is widely recognized, with 27 published articles, 79 citations, and a Scopus h-index of 5. She has collaborated with various national and international researchers to improve neonatal healthcare outcomes. Her contributions extend beyond neonatology to include ophthalmology, pediatric nutrition, and maternal health, demonstrating a broad and interdisciplinary research approach. Dr. Lithoxopoulou is fluent in Greek and English, with strong technical skills in Microsoft Office and data analysis. Her dedication to academia and research makes her a key figure in advancing neonatal healthcare practices. She is committed to improving neonatal treatment protocols, optimizing drug delivery for preterm infants, and reducing neonatal complications through evidence-based research. With a passion for both clinical and academic excellence, she continues to impact neonatology and pediatrics significantly.

Professional Profile

Education

Dr. Maria Lithoxopoulou has a strong academic background in medicine and healthcare management. She earned her Degree in Medicine from Aristotle University of Thessaloniki, Faculty of Medicine, Greece, in 1994, which laid the foundation for her career in pediatrics and neonatology. She later obtained a License to Practice in Paediatrics in 2003, allowing her to specialize in neonatal care. To further advance her expertise, she pursued a Ph.D. in Neonatal Infections, focusing on Signal Transducer and Activator of Transcription in Neonatal Infection, which she completed in 2012 at Aristotle University of Thessaloniki. In addition to her medical training, she obtained an MBA in Health Administration (2017), which equipped her with the necessary skills to manage and lead healthcare units effectively. She later acquired a Medical Specialty in Neonatology after passing rigorous exams. Her multifaceted education combines clinical, research, and administrative expertise, enabling her to contribute significantly to neonatal medicine, hospital management, and academic research. Dr. Lithoxopoulou’s commitment to education and continuous learning has allowed her to excel in both research and patient care, making her a leading figure in the field of pediatric neonatology.

Professional Experience

Dr. Maria Lithoxopoulou has a distinguished career in neonatology, with extensive experience in both clinical practice and academic research. She began her professional journey as a Consultant Neonatologist at General Hospital of G. Papageorgiou, Aristotle University of Thessaloniki, where she served from 2005 to 2022. During her tenure, she played a critical role in treating preterm and critically ill newborns, optimizing neonatal care protocols, and improving neonatal survival rates. In 2022, she transitioned into academia as an Assistant Professor in Paediatrics-Neonatology at Aristotle University of Thessaloniki, where she continues to mentor medical students, supervise research projects, and contribute to cutting-edge neonatal research. Throughout her career, she has collaborated with multidisciplinary teams in pediatric healthcare, focusing on neonatal infections, retinopathy of prematurity, neonatal nutrition, and early neonatal sepsis management. Her expertise extends to hospital administration, research project management, and neonatal pharmacology, allowing her to bridge the gap between clinical care and medical research. Dr. Lithoxopoulou’s contributions have enhanced neonatal treatment protocols, improved screening techniques for neonatal diseases, and shaped the next generation of neonatologists and pediatricians. Her dedication to both patient care and scientific advancement makes her a leading expert in her field.

Research Interests

Dr. Maria Lithoxopoulou’s primary research interests lie in the field of neonatology, with a strong focus on neonatal infections, neonatal ophthalmology, and neonatal nutrition. She has conducted extensive research on retinopathy of prematurity (ROP), exploring innovative screening techniques, drug delivery methods, and treatment outcomes. Her work also delves into neonatal sepsis, thrombocytopenia, and the effects of maternal health on neonatal outcomes, providing valuable insights into early disease detection and intervention strategies. In addition, she has a growing interest in neonatal pharmacology, particularly in optimizing drug delivery methods for preterm infants to improve treatment efficacy. Dr. Lithoxopoulou is also involved in research concerning pediatric nutrition and the prevention of neonatal malnutrition, emphasizing the role of maternal education in child growth and development. Her interdisciplinary approach has led her to collaborate with researchers in ophthalmology, public health, and biomedical sciences, broadening the impact of her work beyond neonatology. She is committed to advancing evidence-based practices in neonatal care by developing new clinical guidelines, conducting systematic reviews, and engaging in large-scale neonatal health studies. Her research significantly contributes to improving neonatal healthcare standards worldwide.

Research Skills

Dr. Maria Lithoxopoulou possesses advanced research skills in neonatology, clinical trials, and medical data analysis. She has expertise in study design, statistical analysis, and systematic reviews, allowing her to conduct high-quality, evidence-based research. She is proficient in using Scopus, ORCID, and Google Scholar for literature review and citation tracking. Her research skills include quantitative and qualitative data analysis, with experience in handling clinical datasets and patient records to draw meaningful conclusions. She has conducted randomized controlled trials, observational studies, and meta-analyses, particularly in neonatal ophthalmology, neonatal pharmacology, and neonatal infections. Additionally, she is skilled in scientific writing and publishing, with 27 published papers in peer-reviewed journals. She collaborates with multidisciplinary research teams, contributing to studies that impact neonatal healthcare on a global scale. Dr. Lithoxopoulou is also adept at grant writing and securing research funding, helping to advance her work in neonatology. With strong skills in Microsoft Office, PowerPoint presentations, and online research tools, she effectively communicates her findings at national and international conferences. Her expertise in data interpretation and clinical application makes her a valuable asset to neonatal research and academic medicine.

Awards and Honors

Dr. Maria Lithoxopoulou has received recognition for her contributions to neonatology and medical research. She has been acknowledged for her work in neonatal ophthalmology, particularly in improving screening techniques for retinopathy of prematurity (ROP). Her research on neonatal infections and thrombocytopenia has been cited as influential in shaping clinical guidelines for neonatal care. Additionally, she has participated in several national and international research projects, earning grants and funding for her innovative studies. Her dedication to neonatology has also been recognized through invitations to speak at international conferences, where she has presented her findings on neonatal pharmacology, neonatal nutrition, and early disease detection in preterm infants. She has contributed to high-impact medical journals and has played a key role in collaborative neonatal research initiatives. While her h-index (5) and citation count (79) are growing, her research continues to gain recognition in the scientific community. Her commitment to advancing neonatal healthcare through cutting-edge research, academic leadership, and clinical excellence makes her a strong candidate for prestigious research awards in pediatrics and neonatology.

Conclusion

Dr. Maria Lithoxopoulou is a highly accomplished neonatologist and researcher with a strong academic background, extensive clinical experience, and a significant research portfolio. Her work in neonatal infections, ophthalmology, and nutrition has led to valuable advancements in neonatal care and treatment protocols. With 27 research publications, a growing citation impact, and numerous contributions to neonatal medicine, she is a leading expert in her field. While she continues to expand her research influence, her commitment to academia, clinical excellence, and medical innovation makes her an outstanding candidate for the Best Researcher Award.

Publications Top Notes

  • Determination of macronutrient profile and energy composition in human milk via Mid‐Infrared Spectrometer Analysis: An experimental study

    • Authors: Maria Lithoxopoulou, Anastasia Gkampeta, Dimitrios Rallis, Katerina Tzafilkou, Eftychia Drogouti, Christos Tsakalidis
    • Year: 2025

  • A hydrophilic interaction liquid chromatography – Tandem mass spectrometry method for the determination of phenylephrine in dried blood spots from preterm infants

    • Authors: E. Boutou, C. Virgiliou, A.K. Seliniotaki, M. Lithoxopoulou, A. Mataftsi, N. Ziakas, E. Diamanti, N. Raikos, H. Gika
    • Year: 2022

  • Avoiding use of lid speculum and indentation reduced infantile stress during retinopathy of prematurity examinations

    • Authors: A. Mataftsi, M. Lithoxopoulou, A.K. Seliniotaki, P. Talimtzi, E. Oustoglou, E. Diamanti, V. Soubasi, N. Ziakas, A.-B. Haidich
    • Year: 2022

  • Population-Based Studies in Retinopathy of Prematurity and Screening Criteria Used

    • Authors: Stella Moutzouri, Aikaterini K. Seliniotaki, Maria Lithoxopoulou, Anna-Bettina Haidich, Nikolaos Ziakas, Asimina Mataftsi
    • Year: 2022

  • Clinical chorioamnionitis and histologic placental inflammation: association with early-neonatal sepsis

    • Authors: D. Rallis, M. Lithoxopoulou, S. Pervana, P. Karagianni, I. Hatziioannidis, V. Soubasi, C. Tsakalidis
    • Year: 2021

  • Efficacy and safety of mydriatic microdrops for retinopathy of prematurity screening: an external pilot crossover randomized controlled trial

    • Authors: A.K. Seliniotaki, M. Lithoxopoulou, P. Talimtzi, E. Georgiou, E. Diamanti, N. Ziakas, A.-B. Haidich, A. Mataftsi
    • Year: 2021

  • Potential benefit from the implementation of the Kaiser Permanente neonatal early-onset sepsis calculator on clinical management of neonates with presumed sepsis

    • Authors: I. Kopsidas, N.-M. Molocha, E. Kourkouni, S. Coffin, D. Gkentzi, E. Chorianopoulou, G. Dimitriou, A. Kapetanaki, G. Karavana, M. Lithoxopoulou, et al.
    • Year: 2021

  • Reducing duration of antibiotic use for presumed neonatal early-onset sepsis in Greek NICUs: A “low-hanging fruit” approach

    • Authors: I. Kopsidas, G.-C. Tsopela, N.-M. Molocha, E. Bouza, E. Chorafa, E. Chorianopoulou, V. Giapros, D. Gkentzi, T. Gkouvas, A. Kapetanaki, et al.
    • Year: 2021

  • A neonate with intrauterine growth restriction and pseudo-Bartter syndrome due to severe maternal eating disorder: A case report

    • Authors: E. Babatseva, I. Chatziioannidis, A.A. Tagaraki, D. Tramma, K. Dampala, E. Chatzitoliou, E. Papacharalambous, G. Mitsiakos, C. Tsakalidis, P. Karagianni, et al.
    • Year: 2020

  • Alternative mydriasis techniques for retinopathy of prematurity screening

    • Authors: A.K. Seliniotaki, E. Prousali, M. Lithoxopoulou, S. Kokkali, N. Ziakas, V. Soubasi, A. Mataftsi
    • Year: 2020

 

Marjan Ghaemi | Medicine and Dentistry | Women Researcher Award

Published on by World Science Awards

Prof. Marjan Ghaemi | Medicine and Dentistry | Women Researcher Award

Prof Tehran university of medical sciences at Iran

Dr. Marjan Ghaemi is an accomplished gynecologist, obstetrician, and infertility specialist with a fellowship in endocrinology. She serves as an Assistant Professor at Vali-E-Asr Reproductive Health Research Center, Tehran University of Medical Sciences. With a strong background in both clinical and research fields, she has dedicated her career to advancing reproductive health. Her expertise spans infertility treatments, reproductive endocrinology, gynecological oncology, and minimally invasive surgery. Additionally, she has played a significant role in medical research and education, holding editorial positions in esteemed journals. Dr. Ghaemi has also contributed to digital health innovations, developing medical IT solutions and e-learning programs. With extensive experience in clinical research, trial management, and evidence-based medicine, she has been instrumental in improving reproductive healthcare. Her leadership in both academia and clinical practice has positioned her as a key figure in the field. Passionate about bridging the gap between research and patient care, she continues to explore new frontiers in reproductive medicine. Her contributions to gynecology and infertility research make her a strong contender for prestigious awards. She strives to integrate cutting-edge technology and medical advancements to enhance women’s healthcare, both nationally and internationally.

Professional Profile

Education

Dr. Marjan Ghaemi has an extensive educational background in medicine, gynecology, and reproductive endocrinology. She obtained her Doctorate in Medicine (MD) from Tehran University of Medical Sciences (TUMS), where she conducted research on the prevalence of polycystic ovary syndrome (PCOS) in adolescents. She further pursued specialization in obstetrics and gynecology at TUMS, achieving the highest national board exam score in OB/GYN in 2019. Her residency research focused on evaluating the quality of life in gynecological cancer patients using a web-based study. Dr. Ghaemi then completed a fellowship in infertility and endocrinology at TUMS, where she conducted a randomized controlled trial comparing different ovarian stimulation protocols in IVF patients with PCOS. Her educational achievements reflect her strong academic foundation and commitment to evidence-based medicine. With a focus on reproductive endocrinology, infertility treatments, and gynecological oncology, her research and clinical training have positioned her as a leader in her field. Her education not only provided her with deep clinical expertise but also honed her research skills, allowing her to contribute significantly to scientific advancements. Through her academic journey, she has consistently demonstrated excellence in both research and patient care, making significant contributions to reproductive medicine.

Professional Experience

Dr. Marjan Ghaemi has a distinguished professional career in clinical practice, academia, and research. She currently serves as an Assistant Professor at Vali-E-Asr Reproductive Health Research Center, TUMS, where she focuses on infertility treatments and reproductive endocrinology. She previously worked as an Assistant Professor at Kamali Hospital, Alborz University of Medical Sciences. Her expertise includes advanced infertility treatments such as in vitro fertilization (IVF), intrauterine insemination (IUI), and minimally invasive gynecological surgeries. Dr. Ghaemi has also played a significant role in scientific publishing, serving as the Chief Editor of Fertility, Gynecology and Andrology and as an Associate Editor for the Journal of Family and Reproductive Health. Her research leadership extends to clinical trials and medical IT innovations. As a Clinical Research Manager at Farzan Clinical Research, she supervised multiple Phase II-IV studies and contributed to the development of digital health solutions, including e-learning platforms and medical applications. She has also worked extensively in hospital settings, managing complex cases in gynecology, obstetrics, and infertility. Her vast experience in research, patient care, and medical education makes her a well-rounded professional dedicated to advancing women’s health and reproductive medicine.

Research Interests

Dr. Marjan Ghaemi’s research focuses on reproductive endocrinology, infertility, and gynecological health. She has a particular interest in polycystic ovary syndrome (PCOS), exploring its prevalence, impact on fertility, and treatment options. Her work in in-vitro fertilization (IVF) has contributed to optimizing ovarian stimulation protocols, improving success rates for women with infertility. She is also interested in recurrent pregnancy loss and male infertility, expanding her research to encompass both partners in reproductive challenges. Additionally, Dr. Ghaemi has investigated the quality of life in gynecological cancer patients, seeking ways to enhance supportive care. Her research extends to hormonal therapies, reproductive surgeries, and minimally invasive techniques, contributing to advancements in assisted reproductive technology (ART). Another key area of her work involves the integration of digital health in reproductive medicine, including e-learning platforms and telemedicine for patient education. She is passionate about bridging the gap between clinical practice and research, ensuring that scientific advancements translate into better patient outcomes. Her multidisciplinary approach combines clinical expertise with innovative research methodologies, making her a leader in reproductive medicine. Through her studies, she aims to improve fertility treatments and reproductive health care, benefiting both patients and the scientific community.

Research Skills

Dr. Marjan Ghaemi possesses advanced research skills in clinical trials, reproductive endocrinology, and gynecological health. She is proficient in designing and conducting randomized controlled trials (RCTs), as demonstrated in her research on ovarian stimulation protocols in IVF. She has extensive experience in medical research methodologies, data analysis, and evidence-based practice. Her expertise in site monitoring, project management, and medical reporting has made her a key contributor to clinical research studies. Additionally, she has strong skills in digital health and medical IT, having developed e-learning platforms, mobile health applications, and smart e-health projects. Dr. Ghaemi’s editorial roles in leading medical journals have enhanced her abilities in scientific publishing, peer review, and manuscript editing. She is also skilled in medical writing and literature reviews, ensuring high-quality contributions to academic publications. Her experience in biostatistics and research ethics allows her to conduct rigorous and ethically sound studies. Furthermore, she has expertise in advanced imaging techniques such as gynecological and infertility ultrasound, enhancing her research capabilities in diagnostic medicine. Her diverse skill set in clinical and digital research makes her a valuable figure in reproductive medicine, contributing to scientific advancements and improved patient care.

Awards and Honors

Dr. Marjan Ghaemi has received several awards and honors in recognition of her academic excellence and contributions to reproductive medicine. She achieved the highest national board exam score in OB/GYN in 2019, demonstrating her outstanding medical knowledge and expertise. Her research on polycystic ovary syndrome (PCOS) and infertility treatments has been acknowledged in various academic and clinical circles. She has also played a pivotal role in medical research and journal editing, earning recognition for her editorial leadership in Fertility, Gynecology and Andrology and Journal of Family and Reproductive Health. As a Clinical Research Manager at Farzan Clinical Research, she was part of a team that earned national recognition as a top knowledge-based institute. Additionally, her contributions to medical IT and e-learning have been praised, as she has led projects in digital health solutions for reproductive medicine. Her work in gynecological cancer quality-of-life studies has also been highlighted in medical research communities. With her achievements in academia, research, and digital innovation, Dr. Ghaemi continues to be recognized as a leading figure in reproductive health and infertility research, making significant contributions to the field.

Conclusion

Dr. Marjan Ghaemi is an exceptional researcher and clinician in reproductive medicine, with expertise spanning gynecology, infertility, and endocrinology. Her contributions to clinical research, medical education, and digital health innovation have positioned her as a leader in the field. With a strong academic background, she has conducted impactful research on PCOS, IVF, and gynecological health, improving fertility treatment outcomes. Her editorial roles in leading journals further emphasize her dedication to advancing scientific knowledge. She has also played a key role in integrating digital health solutions into reproductive medicine, enhancing patient education and research methodologies. While she has achieved significant milestones, expanding her international collaborations and high-impact publications could further elevate her global presence. Overall, her dedication to evidence-based medicine and patient-centered care makes her a strong candidate for prestigious research awards. Dr. Ghaemi’s work is instrumental in shaping the future of reproductive health, and she remains committed to pioneering advancements in infertility treatments and women’s healthcare. With her expertise, leadership, and passion for research, she continues to make remarkable contributions to medical science and patient well-being.

Publications Top Notes

  1. Title: Uterus transplantation: A bibliometric review of six-decade study from 1960 to 2024
    Authors: R. Akbari, M. Ghaemi, Z.Y. Panahi
    Year: 2025
    Citations: 1

  2. Title: The Effectiveness of Letrozole Alone or in Combination with Methotrexate in the Management of Ectopic Pregnancy, A Systematic Review and Meta-Analysis
    Authors: A.M. Tarafdari, F. Keikha, F. Asadi, M. Forouzin, M. Ghaemi
    Year: 2024

  3. Title: Knowledge, attitudes, and practices of healthcare providers among women oncofertility in Iran: a cross-sectional study
    Authors: M. Ghaemi, I. Rokhzadi, M. Dashtkoohi, N. Eshraghi, M. Fakehi
    Year: 2024

  4. Title: Potential efficacy of digital polymerase chain reaction for non-invasive prenatal screening of autosomal aneuploidies: a systematic review and meta-analysis
    Authors: M. Parsaei, M. Dashtkoohi, T. Salmani, M. Ghaemi, S. Hantoushzadeh
    Year: 2024

  5. Title: The association between increased fetal movements in the third trimester and perinatal outcomes; a systematic review and meta-analysis
    Authors: S. Hantoushzadeh, O. Kohandel Gargari, M. Jamali, Z. Panahi, G.R. Habibi
    Year: 2024

  6. Title: Breast Implant Illness as a Challenging Disorder in Clinics
    Authors: F.G. Vahdani, M. Ghaemi, M. Haddadi
    Year: 2024

  7. Title: The association between the amount of fetal fraction in cell-free DNA testing and adverse pregnancy outcomes: A cohort study
    Authors: M. Aryavand, M. Noorzadeh, M. Ghaemi, S.E. Delfan, V. Marsoosi
    Year: 2024

  8. Title: Analysis of medico-legal claims related to deliveries: Caesarean section vs. vaginal delivery
    Authors: N. Eshraghi, M. Ghaemi, Z. Shabannejad, Z. Mansouri, S. Hantoushzadeh
    Year: 2024
    Citations: 1

  9. Title: The effect of Myo-inositol on improving sperm quality and IVF outcomes: A systematic review and meta-analysis
    Authors: M. Ghaemi, N. Seighali, A. Shafiee, Z.Y. Panahi, S. Hantoushzadeh
    Year: 2024
    Citations: 1

 

 

Sami Bahçebaşı | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Dr. Sami Bahçebaşı | Medicine and Dentistry | Best Researcher Award

Internal Medicine at Kayseri City Hospital, Turkey

Sami Bahçebaşı is an experienced internal medicine specialist with a strong background in clinical practice and research. Graduating from Hacettepe University Faculty of Medicine in 2006, he pursued specialization in Internal Medicine at Erciyes University in 2011. Over the years, he has worked in various hospitals, gaining extensive experience in patient care, diagnosis, and treatment. His dedication to medicine extends beyond clinical practice, as he actively contributes to research and healthcare improvements. Currently, he serves as an Internal Medicine Specialist at Kayseri City Hospital, where he manages complex cases and supports clinical education. His skills include patient management, evidence-based medicine, and clinical research. Though his primary language is Turkish, he has an intermediate command of English, which aids in his professional communication. His career objective is to become a distinguished academician and contribute significantly to medical research. While he has made valuable contributions to the field, further enhancement in research publications and international collaborations could elevate his recognition in the academic and medical communities. Sami Bahçebaşı’s continuous dedication to medicine and research makes him a promising figure in the field of internal medicine, with potential for further academic and professional achievements.

Professional Profile

Education

Sami Bahçebaşı completed his Bachelor of Medicine at Hacettepe University Faculty of Medicine in 2006, one of Turkey’s most prestigious medical institutions. His medical education provided him with a strong foundation in fundamental medical sciences, clinical knowledge, and patient care. Following his graduation, he pursued specialization in Internal Medicine at Erciyes University Faculty of Medicine, which he successfully completed in 2011. This specialization enhanced his expertise in diagnosing and managing complex internal medical conditions, preparing him for advanced clinical roles. His education included intensive training in various subfields of internal medicine, including cardiology, gastroenterology, nephrology, and endocrinology. Throughout his academic journey, he actively engaged in clinical rotations, patient case studies, and evidence-based medicine. His studies not only strengthened his medical knowledge but also instilled a research-oriented mindset, motivating him to contribute to scientific advancements. While he possesses a solid educational background, engaging in postgraduate research programs, Ph.D. studies, or fellowships could further enhance his academic standing and research credentials. His continuous pursuit of medical excellence reflects his commitment to lifelong learning and professional growth in the field of internal medicine.

Professional Experience

Sami Bahçebaşı has accumulated significant professional experience in the medical field, spanning nearly two decades. His career began in 2006 at Erciyes University, where he worked as a Medical Intern, gaining hands-on experience in clinical rotations across various departments. From 2011 to 2016, he served as a General Practitioner at District State Hospitals, providing primary healthcare services, diagnosing illnesses, and managing patient treatments in a rural hospital setting. His role involved handling a wide range of medical cases, enhancing his adaptability and problem-solving skills. In 2016, he joined Kayseri Training and Research Hospital as an Internal Medicine Specialist, where he focused on specialized patient care, clinical research, and medical education. Since 2018, he has been working at Kayseri City Hospital as an Internal Medicine Specialist, managing complex cases, collaborating with medical teams, and mentoring junior doctors. His extensive experience across different healthcare settings demonstrates his dedication to improving patient outcomes. While his expertise in internal medicine is well-established, assuming leadership roles in medical research or administrative positions could further solidify his influence in the medical and academic communities.

Research Interest

Sami Bahçebaşı’s research interests primarily revolve around internal medicine, with a focus on improving patient outcomes through clinical advancements and evidence-based medicine. His experience in hospital settings has exposed him to various chronic diseases, prompting his interest in research areas such as cardiovascular diseases, metabolic disorders, endocrinology, and nephrology. His involvement in research at Kayseri Training and Research Hospital suggests a keen interest in exploring innovative treatment approaches, disease prevention strategies, and public health improvements. Additionally, his clinical expertise in patient management and disease diagnosis positions him well for research in epidemiology, clinical trials, and medical education methodologies. To further develop his research profile, engaging in multicenter studies, publishing in high-impact journals, and participating in international medical conferences would be beneficial. Strengthening collaborations with academic institutions and research organizations could also enhance his contributions to the scientific community. While his current research involvement is commendable, expanding his work to include peer-reviewed publications and leadership roles in research projects would further establish him as a leading researcher in internal medicine.

Research Skills

Sami Bahçebaşı possesses several essential research skills that contribute to his effectiveness as a medical professional. His strong analytical skills enable him to critically evaluate medical cases, identify patterns, and interpret clinical data accurately. His experience in evidence-based medicine ensures that his research and clinical decisions are informed by the latest medical advancements and best practices. He is proficient in Microsoft Office Suite, which aids in data management, report writing, and presentation of research findings. Additionally, his moderate proficiency in English allows him to access and analyze international medical literature, although further improvement in language skills would enhance his ability to collaborate globally. His expertise in patient case studies, clinical audits, and medical reviews further demonstrates his research capabilities. To strengthen his research profile, acquiring advanced knowledge in statistical analysis tools (such as SPSS, R, or Python for medical research) and gaining experience in scientific writing for peer-reviewed publications would be highly beneficial. By enhancing his quantitative research methodologies and securing research funding or grants, he could further elevate his contributions to medical research and establish himself as a leading researcher in internal medicine.

Awards and Honors

While Sami Bahçebaşı has made significant contributions to internal medicine, no specific awards or honors are mentioned in his profile. However, his work at Kayseri Training and Research Hospital and Kayseri City Hospital reflects his commitment to medical excellence and research. His role in patient care, medical education, and clinical research indicates recognition within his professional community. To enhance his profile, actively pursuing awards related to clinical excellence, medical research, and healthcare innovation would be beneficial. He could aim for national or international medical awards, research grants, or fellowships to gain wider recognition for his contributions. Participating in medical conferences, research competitions, and academic collaborations could also increase his chances of being acknowledged for his work. Additionally, publishing high-quality research articles in reputable medical journals would improve his academic standing and eligibility for research awards. As he continues to grow in his field, his potential to receive honors and accolades will increase, further solidifying his reputation as a respected internal medicine specialist and researcher.

Conclusion

Sami Bahçebaşı is a dedicated internal medicine specialist with extensive experience in patient care and clinical research. His educational background from Hacettepe University and Erciyes University, coupled with his professional experience in various hospitals, highlights his strong expertise in internal medicine. His research interests in cardiovascular diseases, metabolic disorders, and evidence-based medicine position him as a promising contributor to medical advancements. While he has essential research skills, further enhancing his scientific writing, data analysis, and international collaborations would significantly boost his research profile. Although no awards or honors are currently listed, his commitment to clinical excellence and research suggests strong potential for future recognition. To elevate his career, publishing in high-impact journals, leading research projects, and pursuing academic fellowships would be beneficial. Overall, Sami Bahçebaşı demonstrates great promise as a medical professional and researcher. With continued efforts in research leadership and international collaboration, he could emerge as a distinguished academician and a leading figure in internal medicine research.

Publications Top Notes

  1. “Advantages of Peritoneal Dialysis Over Hemodialysis”

    • Author(s): Sami Bahçebaşı
    • Year: 2022

  2. “The role of oxidants and antioxidative parameters in patients with hepatic encephalopathy”

    • Author(s): Sami Bahçebaşı
    • Year: 2021

  3. “Fear of hypoglycemia in adults with diabetes mellitus switching to treatment with IDegAsp co-formulation to examine real-world setting: an observational study (The HATICE study)”

    • Author(s): Ulaş Serkan Topaloğlu, Hatice Kayış Topaloğlu, Melih Kızıltepe, Mesut Kılıç, Sami Bahçebaşı, Sibel Ata, Şeyma Yıldız, Yasin Şimşek
    • Year: 2020

  4. “Unusual clinical presentation of ethylene glycol poisoning: unilateral facial nerve paralysis”

    • Author(s): Sami Bahçebaşı
    • Year: 2013

  5. “Improvement in culture-negative peritoneal dialysis-related peritonitis: a single center’s experience”

    • Author(s): Sami Bahçebaşı
    • Year: 2012

  6. “Efficacy and safety of deferasirox in patients undergoing stem cell transplantation in post-transplant period”

    • Author(s): Sivgin, S.; Bahcebasi, S.; Kaynar, L.; Kurnaz, F.; Koker, Y.; Cetin, M.; Unal, A.; Eser, B.
    • Year: 2011

  7. “Hepatic and Renal Dysfunction After Using Lavandula Stoechas and Melissa Officinalis Herbal”

    • Author(s): Bahcebasi, Sami; Kocyigit, Ismail; Ucar, Cahit; Unal, Aydin; Oymak, Oktay; Utas, Cengiz
    • Year: 2011

  8. “Efficacy and safety of oral deferasirox treatment in the posttransplant period for patients who have undergone allogeneic hematopoietic stem cell transplantation (alloHSCT)”

    • Author(s): Unknown (needs further verification)
    • Year: 2011

Berta Mosleh | Thoracic Surgery | Best Researcher Award

Published on by World Science Awards

Dr. Berta Mosleh | Thoracic Surgery | Best Researcher Award

Department of Thoracic Surgery from Medical University of Vienna, Austria.

Berta Mosleh, MD, MSc, is a dedicated medical professional with a strong background in thoracic surgery and oncological research. She is currently pursuing a Doctoral Programme in Applied Medical Science at the Medical University of Vienna, focusing on inflammatory proteins and growth factors as biomarkers in malignant pleural mesothelioma. With a medical degree from the Medical University of Vienna and a master’s in economics from Corvinus University of Budapest, she combines clinical expertise with analytical skills. Dr. Mosleh has extensive experience in thoracic surgery, lung cancer research, and minimally invasive surgical procedures. She has contributed significantly to medical literature, with multiple peer-reviewed publications exploring the molecular and clinical aspects of thoracic malignancies. Through her work at Vienna General Hospital and involvement in various research programs, she has gained expertise in interventional bronchoscopy, cytoreductive surgery, and hyperthermic intrathoracic chemotherapy. Her research interests include oncological biomarkers, immunotherapy, and sex-based differences in lung cancer susceptibility. Dr. Mosleh’s commitment to advancing thoracic oncology has earned her recognition in the medical community. With a passion for research and innovation, she strives to enhance treatment strategies and patient outcomes in thoracic malignancies.

Professional Profile

Education

Dr. Berta Mosleh has a multidisciplinary academic background spanning medicine and economics. She is currently enrolled in the Doctoral Programme of Applied Medical Science at the Medical University of Vienna, where she is researching biomarkers for malignant pleural mesothelioma. She obtained her Doctor of Medicine (MD) degree from the Medical University of Vienna in 2019, equipping her with extensive clinical knowledge and surgical expertise. Before transitioning into medicine, Dr. Mosleh earned a Master’s degree in Economics from Corvinus University of Budapest, specializing in Business Administration and Financial Accounting. This diverse academic foundation provides her with a unique perspective on healthcare management and medical research. Throughout her education, she has engaged in numerous internships and research projects, solidifying her expertise in thoracic oncology, minimally invasive surgery, and pulmonary disease management. Her dedication to academic excellence is evident in her ongoing pursuit of medical advancements through research and clinical practice.

Professional Experience

Dr. Berta Mosleh has accumulated a wealth of experience in thoracic surgery and research. Since October 2019, she has been a surgical resident at Vienna General Hospital’s Department of Thoracic Surgery, where she actively participates in the “Thoracic Malignancies Research Program” and the “Malignant Pleural Mesothelioma Treatment and Research Program.” She previously served as a surgical and research intern at the same institution, gaining hands-on experience in minimally invasive procedures and oncological treatments. Dr. Mosleh has also contributed to research in general surgery and pulmonology, undertaking internships in internal medicine, orthopedic surgery, and reconstructive surgery. Her early career included positions in business consulting as a risk advisor at Ernst & Young and a financial auditor at Deloitte. This diverse professional background complements her medical expertise, enhancing her ability to analyze complex healthcare data and optimize clinical decision-making. Her commitment to thoracic oncology and continuous learning makes her an asset in both clinical and research settings.

Research Interests

Dr. Berta Mosleh’s research interests center on thoracic oncology, with a focus on malignant pleural mesothelioma, lung cancer, and pleural disease. She is particularly interested in identifying biomarkers for early diagnosis and treatment response in thoracic malignancies. Her research explores inflammatory proteins, growth factors, and immune checkpoint inhibitors to improve therapeutic strategies. Dr. Mosleh also investigates sex-based differences in lung cancer susceptibility and genetic alterations, aiming to refine personalized treatment approaches. Another key area of her research is the role of immunotherapy and targeted treatments in lung cancer and mesothelioma. Her work extends to the assessment of PD-1 and PD-L1 expression in lung cancer, evaluating their impact on disease progression and patient survival. Through her involvement in multiple studies, she aims to bridge the gap between experimental findings and clinical applications, ultimately improving patient care in thoracic oncology.

Research Skills

Dr. Berta Mosleh possesses a strong skill set in both clinical and laboratory research. She has expertise in biomarker analysis, molecular diagnostics, and immunohistochemistry, allowing her to study disease mechanisms at a cellular level. Her proficiency in clinical trial design and statistical analysis enables her to conduct high-quality medical research. She is skilled in various thoracic surgery techniques, including minimally invasive procedures, interventional bronchoscopy, and cytoreductive surgery. Dr. Mosleh is also adept at medical writing and has authored several peer-reviewed publications. Her ability to collaborate with interdisciplinary teams has been instrumental in advancing research projects. Additionally, her background in economics and data analysis enhances her capacity to assess healthcare trends and optimize treatment strategies. With a strong foundation in both clinical and translational research, she continues to contribute to advancements in thoracic oncology and surgical innovation.

Awards and Honors

Dr. Berta Mosleh has received recognition for her contributions to thoracic surgery and cancer research. Her work in identifying biomarkers for malignant pleural mesothelioma has been acknowledged in academic conferences and peer-reviewed journals. She has been invited to present her findings at prestigious medical symposiums, such as the ÖGP | OGTC Jahrestagung and Cancer Update CCC Vienna. Her research on sex-based differences in lung cancer susceptibility has gained attention within the scientific community. Additionally, her role in evaluating PD-1 and PD-L1 expression in lung cancer has contributed to understanding tumor immunology. Dr. Mosleh’s dedication to medical innovation and patient-centered research has earned her respect among colleagues and mentors. As she continues her research in thoracic oncology, she remains committed to furthering advancements in cancer diagnosis and treatment.

Conclusion

Dr. Berta Mosleh is a highly accomplished thoracic surgeon and researcher, dedicated to advancing the understanding and treatment of lung cancer and malignant pleural mesothelioma. With a solid academic foundation, extensive surgical experience, and a passion for oncological research, she has made significant contributions to the medical field. Her expertise in biomarker discovery, immunotherapy, and minimally invasive procedures positions her at the forefront of thoracic oncology. Through her commitment to scientific research and patient care, Dr. Mosleh continues to drive innovation in cancer treatment. Her ability to integrate clinical practice with research findings ensures that her work has a tangible impact on improving patient outcomes. As she progresses in her career, she remains dedicated to enhancing diagnostic tools, refining therapeutic strategies, and mentoring future medical professionals.

Publications Top Notes

  1. Title: Sex-based differences in lung cancer susceptibility and molecular genetics in the 2020s

    • Authors: B.O. Mosleh, Berta O.; P. Sarova, Pavla; S. Zehetmayer, Sonja; M.A. Hoda, Mir Alireza; D.R. Gompelmann, Daniela Rosa
    • Year: 2025

  2. Title: The impact of restricted chests on long-term lung function parameters following lung transplantation in patients with interstitial lung disease

    • Authors: K. Nakanishi, Keita; T. Schweiger, Thomas; S. Schwarz, Stefan; T.F. Chen-Yoshikawa, Toyofumi Fengshi; K. Hoetzenecker, Konrad
    • Year: 2025
    • Citations: 1

 

Didem Tezen | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Dr. Didem Tezen | Medicine and Dentistry | Best Researcher Award

Istanbul University- Cerrahpasa, Cerrahpasa Faculty of Medicine, Turkey

Dr. Didem Tezen is a dedicated neurologist and researcher with a strong academic background and extensive experience in clinical neurology. She has contributed significantly to the field through her research on neuromuscular disorders, dementia, movement disorders, and neurogenetics. With multiple publications in reputable journals, she has demonstrated expertise in both clinical and molecular neuroscience. Dr. Tezen’s research focuses on the genetic and biochemical mechanisms underlying neurological diseases, aiming to advance diagnostic and therapeutic approaches. She has worked at prestigious institutions, including Istanbul University-Cerrahpaşa and Bakırköy Dr. Sadi Konuk Training and Research Hospital, and currently serves at Oltu State Hospital in Erzurum, Turkey. Her work is highly regarded for its impact on understanding rare neuromuscular syndromes, neuroinflammatory pathways, and neurodegeneration. She actively collaborates with leading experts in neurology and has played a key role in pioneering studies on biomarkers for dementia and genetic mutations in movement disorders. Dr. Tezen’s commitment to scientific discovery and her clinical expertise make her a valuable contributor to the field of neurology. Her growing international presence and dedication to translational research place her among the emerging leaders in neurological research and patient care.

Professional Profile

Education

Dr. Didem Tezen has pursued a distinguished academic journey in medicine and neurology, building a solid foundation for her research and clinical practice. She completed her medical education at Istanbul University, Istanbul Faculty of Medicine from 2011 to 2017, where she developed her fundamental medical knowledge and clinical skills. After graduating, she advanced her expertise by specializing in neurology at Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, between 2018 and 2024. This rigorous residency program provided her with extensive experience in managing a wide range of neurological conditions, including neurodegenerative diseases, neuromuscular disorders, and cerebrovascular diseases. During her studies, she actively participated in clinical research projects and collaborated with experienced faculty members, allowing her to gain practical knowledge in neurophysiology, neuroimaging, and genetic neurology. Her educational background has played a crucial role in shaping her research interests, particularly in biomarker discovery, genetic analysis, and neuroinflammatory mechanisms in neurological disorders. Currently, she continues to apply her knowledge and expand her expertise as a practicing neurologist, while also engaging in ongoing research in her field. Her academic achievements and commitment to lifelong learning highlight her dedication to advancing neurological science and patient care.

Professional Experience

Dr. Didem Tezen has accumulated extensive clinical and research experience throughout her career in neurology. She began her professional journey at Bakırköy Dr. Sadi Konuk Training and Research Hospital, where she worked from 2017 to 2018, gaining firsthand experience in diagnosing and treating a variety of neurological conditions. This period provided her with essential clinical skills and exposure to neurology emergencies and complex neurological disorders. From 2018 to 2024, she further honed her expertise at Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Neurology Department, where she was involved in both clinical neurology and research. During this time, she contributed to several groundbreaking studies focusing on neurodegenerative diseases, neuromuscular disorders, and molecular neurology. She collaborated with esteemed researchers and specialists in neurophysiology, genetics, and electrophysiology, leading to several high-impact publications. As of 2024, Dr. Tezen has been serving as a neurologist at Oltu State Hospital in Erzurum, Turkey, where she continues to provide specialized care to patients with complex neurological disorders. Her clinical expertise, combined with her strong research background, allows her to integrate the latest scientific advancements into patient treatment, making her a highly valued physician and researcher in the field of neurology.

Research Interests

Dr. Didem Tezen’s research interests are primarily focused on the genetic and biochemical mechanisms of neurological diseases, aiming to improve both diagnostic and therapeutic approaches. One of her key areas of interest is neurodegeneration, particularly the role of biomarkers and neuroinflammatory pathways in dementia and Alzheimer’s disease. Her research has explored the clinical significance of YKL-40, VILIP-1, and inflammatory cytokines in neurodegenerative disorders, shedding light on their potential use as biomarkers for disease progression. She is also deeply engaged in studying neuromuscular diseases, with a focus on congenital myasthenic syndromes, hereditary polyneuropathies, and motor neuron diseases. Her investigations into genetic mutations associated with these disorders have provided critical insights into their pathophysiology. Additionally, she has contributed to research on movement disorders, examining rare cases of ADCY5 gene mutations and cerebrotendinous xanthomatosis. Dr. Tezen is also interested in clinical neurophysiology, particularly the application of electromyography (EMG) and nerve conduction studies in diagnosing neuromuscular and movement disorders. Her multidisciplinary approach, integrating genetics, neuroinflammation, and electrophysiology, positions her as a forward-thinking researcher in the field of neurology.

Research Skills

Dr. Didem Tezen possesses a diverse set of research skills that enable her to conduct high-quality scientific investigations in neurology. She is proficient in neurogenetics, with expertise in analyzing genetic mutations related to neuromuscular diseases and movement disorders. Her ability to integrate molecular genetics and clinical findings has significantly contributed to understanding rare neurological conditions. She is also skilled in biomarker research, particularly in the context of dementia and neurodegeneration. Her experience in measuring serum biomarkers, neuroinflammatory markers, and neurodegenerative proteins has advanced the field’s understanding of disease progression and potential treatment targets. In clinical neurophysiology, she has expertise in performing and interpreting electrophysiological tests, such as EMG and nerve conduction studies, which are essential for diagnosing neuromuscular disorders. Additionally, her research involves advanced neuroimaging techniques, including MRI analysis of brain volume changes in dementia patients. Her ability to design clinical studies, analyze statistical data, and collaborate with interdisciplinary teams further enhances her research capabilities. Her strong academic writing skills have also enabled her to publish multiple research papers in peer-reviewed journals, reinforcing her reputation as an accomplished researcher.

Awards and Honors

Dr. Didem Tezen has been recognized for her outstanding contributions to neurology research through several awards and honors. She has received institutional recognition for her work in biomarker discovery and neurogenetics, contributing to a deeper understanding of neurodegenerative and neuromuscular disorders. Her research on biomarkers in dementia and neuroinflammatory pathways has been highly regarded in neurology conferences and academic circles. She has also played a key role in multi-disciplinary research teams that have advanced the field of neuromuscular genetics. In addition to her scientific achievements, Dr. Tezen’s clinical excellence and commitment to patient care have earned her commendations from senior neurologists and faculty members. Her dedication to both research and clinical neurology sets her apart as a well-rounded physician-scientist. With her growing body of work and increasing international presence, she is poised to receive further recognition for her contributions to neurology and neuroscience research in the years to come.

Conclusion

Dr. Didem Tezen is a highly accomplished neurologist and researcher with a strong background in neuromuscular disorders, neurodegeneration, and neurogenetics. Her extensive research output, clinical expertise, and multidisciplinary approach make her a valuable asset to the field of neurology. Her contributions to biomarker discovery, genetic analysis, and electrophysiology have advanced our understanding of neurological diseases, earning her recognition among peers. While she has already established a strong foundation, further expanding her international collaborations, securing research funding, and increasing first-author publications could elevate her to greater scientific prominence. Overall, Dr. Tezen is a deserving candidate for the Best Researcher Award, and her dedication to scientific excellence will continue to have a significant impact on neurology research and patient care.

Scientific Activities

  1. Tezen D, Koçhan Kızılkılıç E, Akkan Suzan A, et al. 2025.

    • Correlation between serum YKL-40 and VILIP 1 levels and brain volume in dementia patients.

  2. Tezen D, Khojakulov Z, Gündüz A, Deymeer F, Demirbilek V, Başak AN. 2024.

    • Clinical, electrophysiological, and genetic analysis of a family with two rare neuromuscular disorders: congenital myasthenic syndrome and hereditary polyneuropathy.

  3. Tezen D, Kızılkılıç EK, Erener N, Khojakulov Z, Demirbilek V, Başak AN. 2025.

    • Experience with salbutamol treatment in a family with congenital myasthenia due to CHRNE mutation.

  4. Tezen D, Savrun F. 2023.

    • Alt Motor Nöron Hastalıkları, in Türkiye Klinikleri Nöroloji Özel Sayı-Motor Nöron Hastalıkları, edited by Nurten Uzun Adatepe.

  5. Gulmammadli N, Konukoğlu D, Merve Kurtuluş E, Tezen D, Ibrahim Erbay M, Bozluolçay M. 2022.

    • Serum Sirtuin-1, HMGB1-TLR4, NF-KB and IL-6 levels in Alzheimer’s: The Relation Between Neuroinflammatory Pathway and Severity of Dementia.

  6. Tezen D, Gunduz A, Erdemir Kiziltan M, Yalcinkaya C, Kiziltan G. 2022.

    • ADCY5 gene mutation: a case report.

  7. Tezen D, Şimşir G, Çokar Ö, Demirbilek V, Başak AN, Yapıcı Z. 2022.

    • Four Turkish families with hyperekplexia: A missense mutation and the exon 1-7 deletion in the GLRA1 gene.

  8. Aktuglu Zeybek C, Gunduz A, Enver EO, Tezen D, Kiykim E, Kızıltan ME. 2020.

    • Movement disorders in the early-diagnosed cerebrotendinous xanthomatosis: An electrophysiological study.

  9. Benbir Şenel G, Tezen D, Tekgül Ş, Başak AN. 2020.

    • Co-existence of Mutations in PRRT2 and ABCC6 Genes in a Turkish Family.

Mycal Dutta | Pharmaceutical Science | Best Researcher Award

Published on by World Science Awards

Dr. Mycal Dutta | Pharmaceutical Science | Best Researcher Award

Associate Professor at University of Science and Technology (USTC), Bangladesh

Dr. Mycal Dutta is an accomplished Associate Professor in the Department of Pharmacy at the University of Science and Technology Chittagong (USTC), Bangladesh. With nearly fourteen years of experience in academia, research, and professional practice, he has made significant contributions to pharmaceutical sciences. Dr. Dutta earned his Ph.D. in Pharmacy from Jahangirnagar University, Dhaka, in December 2022. His expertise spans pharmaceutical technology, microbiology, and clinical pharmacy. He has published 36 research papers in national and international journals, focusing on bioactive phytochemicals, drug formulation, and pharmacological investigations. As a registered “A” Grade Pharmacist, he actively contributes to professional training and advisory committees. His research interests include the isolation of medicinal plant compounds, computational drug design, and molecular docking studies. Dr. Dutta has received several research grants, including government-funded projects on ethnomedicinal plants. Apart from his academic roles, he has been involved in organizing scientific conferences and student welfare activities. His commitment to teaching, research, and pharmaceutical advancements has made him a distinguished figure in the field.

Professional Profile

Education

Dr. Mycal Dutta has a strong academic background in pharmacy. He obtained his Ph.D. in Pharmacy from Jahangirnagar University, Dhaka, in December 2022. Prior to this, he completed his Master of Pharmacy (Thesis) degree from Southern University, Bangladesh, in 2011, achieving a CGPA of 3.6 on a 4.0 scale. He earned his Bachelor of Pharmacy (Hons.) degree from the University of Science and Technology Chittagong (USTC) in 2009, graduating with First Class honors. His foundational education includes a Higher Secondary Certificate (HSC) from Govt. Hazi Muhammad Mohsin College, Chittagong, with a GPA of 4.70 out of 5.00 in 2004, and a Secondary School Certificate (SSC) from Collegiate School, Chittagong, with a GPA of 4.38 out of 5.00 in 2002. His educational journey reflects his dedication to academic excellence and pharmaceutical sciences.

Professional Experience

Dr. Mycal Dutta has extensive teaching and research experience in the field of pharmacy. He has been serving as an Associate Professor at the University of Science and Technology Chittagong (USTC) since July 2023. Previously, he worked as an Assistant Professor at BGC Trust University Bangladesh for nearly eight years (2015–2023) and as a Lecturer at the same institution for almost five years (2011–2015). In addition to his teaching roles, he has contributed significantly to academic administration, including serving as an advisor in the Student Welfare Advisory Committee at USTC and as Chief Advisor of the Career Development and Placement Club at BGC Trust University. His professional contributions extend to chairing scientific and publication committees for national conferences and participating in examination committees. His vast experience demonstrates his dedication to pharmacy education and academic leadership.

Research Interests

Dr. Mycal Dutta’s research interests focus on pharmacological and phytochemical investigations of medicinal plants. His work involves compound isolation using techniques such as Nuclear Magnetic Resonance (NMR) and Gas Chromatography-Mass Spectrometry (GC-MS). He is particularly interested in computational drug discovery, molecular docking, Quantitative Structure-Activity Relationship (QSAR) modeling, and ADME/T property analysis of natural compounds. His research aims to bridge wet lab and dry lab approaches to develop therapeutic solutions from natural products. He also explores antimicrobial studies, aseptic techniques, bacterial staining, and in vitro and in vivo pharmacological investigations. His research contributions significantly advance the understanding of bioactive phytochemicals and their therapeutic potential.

Research Skills

Dr. Mycal Dutta possesses a diverse range of research skills, including microbiological techniques such as aseptic handling, bacterial staining, and antimicrobial sensitivity testing. He is proficient in computational drug design, protein modeling, and molecular simulations. His technical expertise extends to animal research, including transgenic and knockout mouse models. He is skilled in using various molecular modeling and Computer-Aided Drug Design (CADD) software. Additionally, he has extensive experience with statistical analysis tools such as GraphPad Prism and SPSS. His proficiency in these areas enables him to conduct high-quality research and mentor students in advanced pharmaceutical investigations.

Awards and Honors

Dr. Mycal Dutta has received several prestigious research grants and recognitions. He was awarded the R&D Grant for Science and Technology (2022–2023) from the Ministry of Science and Technology, Bangladesh, for his research on bioactive phytochemicals. Additionally, he secured a research grant from BGC Trust University Bangladesh in 2017 to support his Ph.D. research. His contributions to pharmaceutical research have been acknowledged through numerous publications in high-impact journals. He has also played a key role in organizing national conferences and scientific symposiums. His commitment to research and academia has earned him a strong reputation in the field of pharmaceutical sciences.

Conclusion

Dr. Mycal Dutta is a dedicated researcher, educator, and pharmaceutical scientist committed to advancing pharmaceutical education and research. With nearly fourteen years of experience, he has made remarkable contributions to pharmacology, phytochemistry, and drug discovery. His extensive research on medicinal plants and computational drug design has positioned him as a leading expert in the field. His passion for teaching, mentoring students, and conducting groundbreaking research continues to impact the pharmaceutical sciences significantly. Through his academic leadership, professional affiliations, and research initiatives, he remains at the forefront of pharmaceutical innovation and education.

Publications Top Notes

  1. Yusuf, A., Shaikat, M. A., Bhuiya, M. A. M., Dutta, M., Nath, A. K., & Dash, P. R. (2023). Utilizing the Medicinal Properties of Delonix regia for Diseases and Beyond: A Review of its Phytochemistry and Pharmacology. Tropical Journal of Natural Product Research, 7(12), 5355–5365. DOI: 10.26538/tjnpr/v7i12.2

  2. Malini, S., Raj, K., Madhumathy, S., El-Hady, K. M., Islam, S., & Dutta, M. (2022). Bioinspired Advances in Nanomaterials for Sustainable Agriculture. Journal of Nanomaterials, 2022, Article ID 8926133. DOI: 10.1155/2022/8926133

  3. Vaidya, S., Jeengar, M., Wadaan, M. A., Mahboob, S., Kumar, P., Reece, L. M., Bathula, S. R., & Dutta, M. (2022). Design and In Vitro Evaluation of Novel Cationic Lipids for siRNA Delivery in Breast Cancer Cell Lines. Evidence-Based Complementary and Alternative Medicine, 2022, Article ID 9231641. DOI: 10.1155/2022/9231641

  4. Jadhav, V., Bhagare, A., Wahab, S., Lokhande, D., Vaidya, C., Dhayagude, A., Khalid, M., Aher, J., Mezni, A., & Dutta, M. (2022). Green Synthesized Calcium Oxide Nanoparticles (CaO NPs) Using Leaves Aqueous Extract of Moringa oleifera and Evaluation of Their Antibacterial Activities. Journal of Nanomaterials, 2022, Article ID 9047507. DOI: 10.1155/2022/9047507

  5. Jadhav, V., Bhagare, A., Ali, I. H., Dhayagude, A., Lokhande, D., Aher, J., Jameel, M., & Dutta, M. (2022). Role of Moringa oleifera on Green Synthesis of Metal/Metal Oxide Nanomaterials. Journal of Nanomaterials, 2022, Article ID 2147393. DOI: 10.1155/2022/2147393

  6. Alharthy, S. A., Shams Tabrez, S., Ahmed A. Mirza, A. A., Torki A. Zughaibi, Firoz, C. K., & Dutta, M. (2022). Sugiol Suppresses the Proliferation of Human U87 Glioma Cells via Induction of Apoptosis and Cell Cycle Arrest. Evidence-Based Complementary and Alternative Medicine, 2022, Article ID 7658899. DOI: 10.1155/2022/7658899

  7. Dutta, M., Akter, T., Nezam, M., Paul, A., & Rana, M. S. (2022). In silico Molecular Docking and ADME/T Analysis of Selected Bioactive Compounds from Leucas zeylanica against Breast Cancer. BGC Trust University Journal, 6, 51–66.

  8. Dutta, M., Tareq, A. M., Rakib, A., Mahmud, S., Sami, S. A., Mallick, J., Islam, M. N., Majumder, M., Uddin, M. Z., Alsubaie, A., & Almalki, A. S. (2021). Phytochemicals from Leucas zeylanica Targeting Main Protease of SARS-CoV-2: Chemical Profiles, Molecular Docking, and Molecular Dynamics Simulations. Biology, 10(8), 789. DOI: 10.3390/biology10080789

  9. Dutta, M., Nezam, M., Chowdhury, S., Rakib, A., Paul, A., Sami, S. A., Uddin, M. Z., Rana, M. S., Hossain, S., Effendi, Y., Idroes, R., Tallei, T. E., Alqahtani, A. M., & Emran, T. B. (2021). Appraisals of the Bangladeshi Medicinal Plant Calotropis gigantea Used by Folk Medicine Practitioners in the Management of COVID-19: A Biochemical and Computational Approach. Frontiers in Molecular Biosciences, 8, 625391. DOI: 10.3389/fmolb.2021.625391

  10. Rakib, A., Paul, A., Ahmed, S., Chy, M. N. U., Baral, S. K., Majumder, M., Tareq, A. T., Amin, M. N., Shahriar, A., Uddin, M. Z., Dutta, M., Tallei, T. E., Emran, T. B., & Simal-Gandara, J. (2020). Biochemical and Computational Approach of Phytocompounds from Tinospora crispa in the Management of COVID-19: Molecules; 25(17): E3936. DOI: 10.3390/molecules25173936

Xiongfei Xu | Medicine and Dentistry | Excellence in Research

Published on by World Science Awards

Dr. Xiongfei Xu | Medicine and Dentistry | Excellence in Research

Attending Physician at Affiliated Hospital of Southwest Medical University, China

Dr. Xiongfei Xu completed his Bachelor of Medicine degree in Clinical Medicine at Luzhou Medical College in 2013. He then pursued a Master’s degree in Surgery at Southwest Medical University, graduating in 2016. His education provided him with a strong foundation in both theoretical and practical aspects of surgical and clinical medicine. Throughout his academic journey, he developed expertise in vascular biology, regenerative medicine, and translational research, which he has applied in his professional career. Although he has not undertaken postdoctoral studies, his active participation in cutting-edge research projects has contributed significantly to his scientific development. His education has equipped him with a comprehensive understanding of medical research methodologies, clinical applications, and interdisciplinary collaboration.

Professional Profile

Professional Experience

Dr. Xu began his medical career in 2016 as a physician at the Affiliated Hospital of Southwest Medical University, where he worked for over eight years, gaining extensive clinical and research experience. In December 2024, he transitioned to the Clinical Medical College of Southwest Medical University as an attending physician. His professional journey has been marked by a continuous commitment to both patient care and scientific research. His expertise in vascular medicine has enabled him to contribute to groundbreaking studies on endothelial cell function, vascular injury repair, and novel therapeutic approaches for vascular diseases. Dr. Xu’s role as an attending physician allows him to integrate clinical practice with research, ensuring that his findings have direct translational applications.

Research Interests

Dr. Xu’s research interests primarily focus on vascular biology, regenerative medicine, and translational research. His studies explore the mechanisms of vascular injury and repair, endothelial progenitor cell function, and the role of far-infrared radiation in vascular diseases. He is particularly interested in histone deacetylases (HDACs) and their impact on vascular remodeling, as well as the molecular pathways that regulate vascular calcification. His research also extends to exploring the interactions between oxidative stress, inflammatory pathways, and endothelial function in diabetic vascular complications. By investigating novel therapeutic strategies, Dr. Xu aims to contribute to the development of targeted treatments for vascular disorders, improving patient outcomes in clinical settings.

Research Skills

Dr. Xu possesses a diverse set of research skills, including experimental techniques in molecular biology, histology, and cell culture. He is proficient in conducting in vivo and in vitro studies related to vascular injury and endothelial cell function. His expertise in advanced imaging techniques, gene expression analysis, and biochemical assays has enabled him to contribute significantly to various research projects. Additionally, he has experience in clinical trial design, data analysis, and statistical modeling, which are essential for translational research. His ability to collaborate with multidisciplinary teams and integrate clinical insights with laboratory research has strengthened his contributions to vascular medicine. Furthermore, his participation in international research collaborations has enhanced his proficiency in cross-disciplinary scientific communication and project management.

Awards and Honors

Although Dr. Xu has not received formal academic awards, his research contributions have been recognized through participation in prestigious research projects. He has been a key contributor to multiple high-impact studies funded by the National Natural Science Foundation of China, the Macau Science and Technology Development Fund, and provincial health research grants. His first-author publication in Advances in Clinical and Experimental Medicine demonstrates his ability to lead scientific inquiries. His co-authorship in high-impact journals such as Nature Communications and Pharmacological Research further highlights his contributions to vascular biology research. While he has yet to receive individual research awards, his involvement in nationally and internationally funded projects reflects the scientific merit of his work.

Conclusion

Dr. Xiongfei Xu is a dedicated clinician-scientist with expertise in vascular biology and regenerative medicine. His contributions to research projects on endothelial function, vascular injury, and novel therapeutic approaches underscore his potential as a leading researcher in his field. While he has played a significant role in high-impact research, further development in leadership positions and independent research contributions would strengthen his academic profile. Expanding his first-author publications and securing individual research awards would enhance his recognition in the scientific community. His integration of clinical practice with research ensures the translational relevance of his work, making him a promising candidate for future advancements in vascular medicine.

 

Bassem Al Hariri | Health Professions | Best Researcher Award

Published on by World Science Awards

Assist. Prof. Dr.  Bassem Al Hariri | Health Professions | Best Researcher Award

Assist. Prof. Dr. from Hamad Medical corporation, Qatar

Dr. Bassem Naif Altaleb Alhariri is a distinguished specialist in Internal Medicine and Pulmonary Diseases with extensive experience in clinical practice, medical education, and research. He is currently a Consultant in Internal Medicine & Pulmonology at Hamad Medical Corporation’s Hazm Mebaireek General Hospital in Qatar. Born in Syria on November 1, 1977, Dr. Alhariri has dedicated his career to providing high-quality medical care, mentoring young professionals, and contributing to research in his field. His expertise spans respiratory disorders, emergency medicine, and intensive care, along with a strong background in academic training and committee leadership. With multiple board certifications and international medical licensure, he has made significant contributions to internal medicine and pulmonology.

Professional Profile

Education

Dr. Alhariri earned his MD in General Medicine from Damascus University in 2004. He pursued a specialization in Internal Medicine, receiving his certification from the Syrian Ministry of Health in 2009. Furthering his expertise, he completed a specialization in Pulmonary Diseases in 2013. His postgraduate training included rigorous residency programs at Damascus’s top university hospitals, providing extensive exposure to various medical subspecialties. He holds board certifications in both Internal Medicine and Pulmonary Diseases from the Syrian Board, demonstrating his commitment to excellence in patient care and medical practice.

Professional Experience

Dr. Alhariri has amassed a wealth of experience across multiple medical institutions. He began his career in Syria, serving as a Senior Specialist in Internal Medicine at several government hospitals, later becoming the Head of Department at Izraa Hospital. From 2013 to 2016, he worked as a Consultant in Internal Medicine and Pulmonology, including humanitarian efforts with the International Medical Corps. Since 2017, he has been practicing in Qatar, first at a polyclinic and later at Hamad Medical Corporation. His expertise includes emergency care, intensive care unit (ICU) management, outpatient pulmonary services, and complex diagnostic procedures such as bronchoscopy, thoracoscopy, and lung biopsies.

Research Interests

Dr. Alhariri is deeply involved in medical research, focusing on respiratory disorders, critical care, and emerging treatments in pulmonology. His work includes studying innovative diagnostic techniques and therapeutic approaches for chronic respiratory diseases. As a member of Hamad Medical Corporation’s research committee, he actively contributes to clinical studies and the advancement of evidence-based medicine. His research interests align with improving patient outcomes through novel interventions, medical education strategies, and the integration of advanced diagnostic tools in pulmonary medicine.

Research Skills

Dr. Alhariri possesses strong research skills in clinical case analysis, medical data interpretation, and systematic reviews. His expertise extends to conducting hospital-based research, analyzing patient outcomes, and developing treatment protocols for respiratory conditions. As a reviewer for Clinical Case Reports Journal (Wiley), he critically evaluates medical research publications. His research methodology includes case-control studies, cohort analyses, and qualitative assessments of medical interventions. His ability to integrate clinical practice with research enhances his role as both a physician and an academic mentor.

Awards and Honors

Dr. Alhariri has been recognized for his contributions to medical education, clinical excellence, and research. He has served as an examiner for the Objective-Structured Clinical Exam (OSCE) at Qatar University and as a faculty member at Weill Cornell Medicine-Qatar. His leadership roles include membership in the Clinical Practice Guidelines (CPG) committee and education committees at Hamad Medical Corporation. His dedication to teaching has earned him appointments as a clinical lecturer at Qatar University and an assistant professor at Weill Cornell Medicine-Qatar. These honors reflect his commitment to fostering the next generation of medical professionals.

Conclusion

Dr. Bassem Naif Altaleb Alhariri is a highly accomplished medical professional with a deep passion for patient care, medical education, and research. His extensive experience in internal medicine and pulmonology, combined with his active role in academic training and clinical research, has positioned him as a key contributor to the field. With his unwavering dedication to medical excellence, Dr. Alhariri continues to impact healthcare in Qatar and beyond, shaping the future of respiratory medicine and mentoring aspiring physicians. His commitment to lifelong learning and innovation makes him a respected leader in his specialty.

Publications Top Notes

  1. Case of severe thrombocytopenia with recurrent extensive deep vein thrombosis due to antiphospholipid syndrome, management challenge

    • Authors: Bassem Al Hariri, Gaydaa Ali Ahmed Ali, Arwa Elfatih Mohamed Ali, Mohamed Elfatih MohamedAli, Feroz Jenner Poolakundan, Muhammad Sharif, Memon Noor Illahi
    • Year: 2025

  2. A rare case presentation of gastrointestinal stromal tumor (GIST) in a young adult patient

    • Authors: Bassem Al Hariri, Rawan S. Mohamed, Hadil Altaj Altrify Alsidig, Abdulqadir J. Nashwan, Muad Abdi Hassan
    • Year: 2024

  3. An adolescent presenting with Caroli syndrome associated with polycystic kidney disease: A case report

    • Authors: Bassem Al Hariri, Vajeeha Haider, Memon Noor Illahi, Muhammad Sharif, Abdulqadir J. Nashwan
    • Year: 2024

  4. An idiopathic severe macroglossia in a young adult patient: a rare case

    • Authors: Bassem Al Hariri, Muad A. Hassan, Muhammad Sharif, Rawan S. Mohamed, Hadil A. A. Alsidig, Hadil A. A. Alsiddig, Memon N. Illahi
    • Year: 2024

  5. Brucellosis an Unusual presentation as isolated septic mono-arthritis of the knee joint: A case report

    • Authors: Muad A. Hassan, F. Noor, A. Salehi, Bassem Al Hariri
    • Year: 2024

  6. Correction to “Spontaneous hemothorax caused by rivaroxaban treatment for pulmonary embolism: a case report.”

    • Authors: Bassem Al Hariri, A. Alharafsheh, M. A. Hassan, A. J. Nashwan, M. G. Mohamedali, H. M. Abusriwil
    • Year: 2024

  7. Effect of pioglitazone on inflammatory response and clinical outcome in T2DM patients with COVID-19: a randomized multicenter double-blind clinical trial

    • Authors: K. Baagar, T. Alessa, M. Abu-Farha, J. Abubaker, H. Alhumaidi, J.A. Franco Ceruto, M.K. Hamad, A. Omrani, S. Abdelrahman, M. Zaka-Ul Haq, et al.
    • Year: 2024

  8. Periodic Paralysis: A Case Series with a Literature Review

    • Authors: Bassem Al Hariri, Muad A. Hassan, Muhammad Sharif, O. A. Alsakaji, Y. A. Hassan, M. K. Khalid
    • Year: 2024

  9. Streptococcus cristatus: An uncommon cause for a common hospital admission

    • Authors: U. Al-Anbagi, A. Salehi, G. J. Wilson, F. Noor, A. O. Mohamed, A. Haji, A. J. Nashwan, H. A. Nasir, Bassem A. Hariri
    • Year: 2024

  10. Unusual isolated splenic hydatid cyst: A case report

  • Authors: Bassem Al Hariri, Vajeeha Haider, Mamunul Islam, Abdalrahman Mohammed Mostafa, Ahmad Eid Nazzal Alharafsheh, Memon Noor Illahi
  • Year: 2024

 

Ahmed Maged | Health Professions | Best Researcher Award

Published on by World Science Awards

Prof. Dr. Ahmed Maged | Health Professions | Best Researcher Award

Professor at Faculty of medicine, Egypt

Professor Ahmed Maged is a distinguished academic specializing in obstetrics and gynecology. He holds the position of Professor at Cairo University’s Kasr Alainy Faculty of Medicine, where he has been a faculty member since January 2012. His extensive research portfolio includes over 79 publications, with a focus on systematic reviews and meta-analyses in women’s health. Notably, his recent work has addressed critical topics such as postpartum hemorrhage prevention and the use of misoprostol in gynecological procedures. Beyond his research, Professor Maged contributes to the academic community as an associate editor for Springer Nature and serves as a reviewer for the Supreme Council of Universities. His dedication to advancing medical knowledge and education underscores his significant role in the field of obstetrics and gynecology.

Professional Profile

Education:

Professor Maged completed his medical education at Cairo University’s Kasr Alainy Faculty of Medicine, earning his MD in 1997. He has since advanced his academic career, achieving the rank of Professor in Obstetrics and Gynecology by 2016. His educational journey reflects a commitment to excellence in medical education and a dedication to the field of obstetrics and gynecology.

Professional Experience:

Since January 2012, Professor Maged has been serving as a Professor of Obstetrics and Gynecology at Cairo University’s Kasr Alainy Faculty of Medicine. In this role, he has been instrumental in educating and mentoring medical students and residents, contributing to the advancement of medical knowledge and practice. His professional experience is further enriched by his involvement in various academic committees and his role as a reviewer for the Supreme Council of Universities, reflecting his active engagement in the academic community.

Research Interests:

Professor Maged’s research interests are centered on women’s health, with a particular focus on obstetrics and gynecology. He has conducted extensive studies on postpartum hemorrhage prevention, the use of misoprostol in gynecological procedures, and the impact of laser acupuncture on metabolic syndrome in obese postmenopausal women. His work aims to improve clinical practices and patient outcomes in these areas.

Research Skills:

Professor Maged possesses advanced research skills, including systematic reviews and meta-analyses, which have been pivotal in synthesizing existing literature and providing evidence-based recommendations in obstetrics and gynecology. His ability to critically evaluate and integrate research findings demonstrates a high level of expertise in research methodology and data analysis.

Awards and Honors:

While specific awards and honors are not detailed in the provided information, Professor Maged’s significant contributions to research and education in obstetrics and gynecology are evident through his extensive publication record and leadership roles in academic committees. His recognition as an associate editor for Springer Nature and as a reviewer for the Supreme Council of Universities highlights his esteemed position in the academic community.

Conclusion:     

Professor Ahmed Maged’s dedication to the field of obstetrics and gynecology is evident through his extensive research, educational contributions, and active involvement in the academic community. His work has significantly advanced understanding and clinical practices in women’s health. His commitment to excellence in research and education underscores his esteemed position in the medical community.

Publications Top Notes

  1. Expression of Concern: Carbetocin versus oxytocin in the management of atonic postpartum hemorrhage (PPH) after vaginal delivery: a randomized controlled trial

    • Authors: A.M. Mohamed Maged, Ahmed Mohamed, A.G.M.A. Hassan, Abdel Gany M.A., N.A.A. Shehata, Nesreen A.A.
    • Year: 2025

  2. A systematic review and meta-analysis of randomized trials comparing carbetocin to oxytocin in prevention of postpartum hemorrhage after cesarean delivery in low-risk women

    • Authors: A.M. Mohamed Maged, Ahmed Mohamed, N.A. El-Goly, Nour A., D. Turki, Doaa, N. Bassiouny, Nehal, N.M. El-Demiry, Nihal Mostafa
    • Year: 2025

  3. The value of misoprostol administration before intrauterine contraceptive device insertion: a systematic review and meta-analysis

    • Authors: A.M. Mohamed Maged, Ahmed Mohamed, N.A. El-Goly, Nour A., N. Bassiouny, Nehal, N.M. El-Demiry, Nihal Mostafa, S. AbdelAziz, Suzi
    • Year: 2024

  4. The use of misoprostol before hysteroscopy in nulliparous women: a systematic review and meta-analysis of randomized controlled trials

    • Authors: N.M. Salah, Noha M., A.M. Mohamed Maged, Ahmed Mohamed, S.I. Mahmoud, Safaa Ibrahim, S. AbdelAziz, Suzi, W.S. Ragab, Wael Samir
    • Year: 2024
    • Citations: 0

  5. The effects of laser acupuncture on metabolic syndrome in obese postmenopausal women: a randomized controlled study

    • Authors: W.M. Kamal, Wafaa Mohammad, A.M. Mohamed Maged, Ahmed Mohamed, S. AbdelAziz, Suzi, S.I. Mahmoud, Safaa Ibrahim, R.A. Mohsen, Reham A.
    • Year: 2024

  6. Impact of treatment interventions of endometriomas prior to in vitro fertilization: a systematic review and meta-analysis

    • Authors: M.A. Katta, Maha Ali, A.M. Mohamed Maged, Ahmed Mohamed, A.I. Ogila, Asmaa I., W.S. Ragab, Wael Samir
    • Year: 2024

  7. The value of intraovarian autologous platelet-rich plasma in women with poor ovarian reserve or ovarian insufficiency: a systematic review and meta-analysis

    • Authors: A.M. Mohamed Maged, Ahmed Mohamed, R.A. Mohsen, Reham A., N.M. Salah, Noha M., W.S. Ragab, Wael Samir
    • Year: 2024
    • Citations: 3

  8. Erratum to: Maternal serum homocysteine and uterine artery Doppler as predictors of preeclampsia and poor placentation

    • Authors: A.M. Mohamed Maged, Ahmed Mohamed, H. Saad, Hany, H. Meshaal, Hadeer, W.S. Deeb, Wesam Sayed, M.A. Katta, Maha Ali
    • Year: 2024

  9. RETRACTED ARTICLE: A randomized controlled study of the effect of hyoscine butylbromide on duration of labor in primigravida women with prolonged labor

    • Authors: A.M. Mohamed Maged, Ahmed Mohamed, E.H. Sorour, Ehab H., M.M. ElSadek, Mostafa M., S.M. Hassan, Sarah Mohamed, A.Y. Shoab, Amira Y.
    • Year: 2024

 

Ji-Chang Zhou | Health Professions | Best Researcher Award

Published on by World Science Awards

Assoc. Prof. Dr Ji-Chang Zhou| Health Professions| Best Researcher Award|

University Professor from Sun Yat-sen University – Shenzhen Campus, china.

Dr. Ji-Chang Zhou is an Associate Professor and Principal Investigator at the School of Public Health (Shenzhen), Sun Yat-sen University. He earned his degree in Public Health from the West China University of Medical Sciences in 2000 and completed postgraduate studies at Sichuan University in 2005. His research focuses on nutritional biology, particularly the roles of selenium and vitamin D in metabolic health, chronic diseases, and cognitive decline. Dr. Zhou previously served as a Postdoctoral Associate at Cornell University and led research at the Shenzhen Center for Chronic Disease Control. He has published extensively in top journals and received recognition for his contributions to public health and nutrition science. 🚀📚

Professional Profile

Education

Dr. Ji-Chang Zhou pursued his undergraduate studies at the West China University of Medical Sciences, completing his degree in Public Health in 2000. He then continued his postgraduate education at Sichuan University, where he specialized in public health and obtained his degree in 2005. His academic training provided him with a strong foundation in medical sciences and public health research, particularly focusing on nutritional biology.

Professional Experience

Dr. Ji-Chang Zhou is an Associate Professor and Principal Investigator at the School of Public Health (Shenzhen), Sun Yat-sen University, where he has been working since July 2018. Before this role, he was a Postdoctoral Associate at the Department of Animal Science, Cornell University, from 2015 to 2016. His previous experience includes leading research at the Molecular Biology Laboratory of the Shenzhen Center for Chronic Disease Control for nearly a decade. Earlier in his career, he worked as a Research Assistant at the International Center of Future Agriculture for Human Health, Sichuan Agricultural University. His extensive experience across academic and research institutions has solidified his expertise in nutritional biology, chronic disease prevention, and public health.

Research Interests

Dr. Zhou specializes in the nutritional biology of selenium and vitamin D, focusing on their roles in health and disease. His research explores how these essential nutrients influence muscle strength, metabolic disorders, and chronic diseases such as diabetes and cardiovascular conditions. He also investigates the interaction between vitamins and heavy metal toxicity, as well as the molecular mechanisms of nutrient-related cognitive decline. His work aims to develop nutritional interventions that can mitigate disease risks and improve public health.

Selected Publications

Dr. Zhou has authored numerous high-impact research articles in prestigious journals such as The Journal of Nutrition, PLoS ONE, Journal of Neurology, and Food & Function. His studies cover a wide range of topics, including the effects of vitamin D on muscle strength, the role of selenium in metabolic health, and the impact of dietary interventions on chronic diseases. Notable publications include research on vitamin D’s influence on testosterone levels, the association between heavy metals and diabetes risk, and the genetic factors affecting lipid metabolism. His work has significantly contributed to the understanding of nutrition-related health challenges.

Awards and Honors

Dr. Zhou has been recognized for his contributions to public health and nutritional sciences. His research has received funding from prestigious institutions, and his work has been cited extensively in academic literature. His studies on selenium and vitamin D metabolism have earned him accolades for their impact on global health. His participation in international research collaborations, including his postdoctoral work at Cornell University, further highlights his academic excellence and leadership in the field.

Conclusion

With an impressive academic background, extensive research experience, and significant contributions to nutritional biology, Dr. Ji-Chang Zhou is a strong candidate for the Best Researcher Award. His pioneering work in selenium and vitamin D research has advanced the understanding of these nutrients’ impact on human health. While his research output is remarkable, expanding his collaborations with global health organizations could further enhance the real-world application of his findings. Nonetheless, his expertise and dedication to scientific excellence make him highly deserving of recognition in the field of public health and nutritional sciences.

Publication Top Noted

  1. Evaluation of the Role of Tanshinone I in an In Vitro System of Charcot-Marie-Tooth Disease Type 2N

    • Authors: Zhang, Jingjing; Meng, Xinru; Qin, Qianni; Zhou, Jichang; Sun, Litao
    • Journal: International Journal of Molecular Sciences
    • Year: 2024

  2. Alleviation of Lipid Disorder and Liver Damage in High-Fat Diet-Induced Obese Mice by Selenium-Enriched Cardamine violifolia with Cadmium Accumulation

    • Authors: Zhu, Junying; Lv, Qingqing; Li, Fengna; Lei, Xingen; Zhou, Jichang
    • Journal: Nutrients
    • Year: 2024
    • Citations: 1

  3. Endoplasmic Reticulum-Resident Selenoproteins and Their Roles in Glucose and Lipid Metabolic Disorders

    • Authors: Shi, Zhan; Han, Ziyu; Chen, Jingyi; Zhou, Jichang
    • Journal: Biochimica et Biophysica Acta – Molecular Basis of Disease
    • Year: 2024
    • Citations: 2

  4. Selenoprotein H Mediates Low Selenium-Related Cognitive Decline Through Impaired Oligodendrocyte Myelination with Disrupted Hippocampal Lipid Metabolism in Female Mice

    • Authors: Lv, Qingqing; Yang, Aolin; Han, Ziyu; Chen, Yuqing; Zhou, Jichang
    • Journal: Biochimica et Biophysica Acta – Molecular Basis of Disease
    • Year: 2024